Nearinfrared photoimmunotherapy uses an antibodyphotoabsorber conjugate that binds to cancer cells. When nearinfrared light is applied, the cells swell and then burst, causing the cancer cell to die. Photoimmunotherapy is in clinical trials in patients with inoperable tumors. For more information, please visit
0
0
Related videos
Preparing
To view the site materials you should be more than or equal to 18 years old